Innate Pharma S.A. (IPHA)

Innate Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	167	225	298	360	321	481
Market Cap Growth	-37.44%	-24.35%	-17.31%	12.13%	-33.20%	-
Enterprise Value	110	167	235	274	160	256
PE Ratio	-	-26.80	-4.82	-6.00	-4.12	-20.63
PS Ratio	2.43	3.29	4.86	12.84	3.78	5.01
PB Ratio	2.99	3.91	5.17	2.95	1.69	1.97
P/FCF Ratio	-6.19	-6.19	-14.23	-5.34	-5.00	12.72
P/OCF Ratio	-6.23	-6.23	-14.62	-5.42	-5.09	12.26
EV/Sales Ratio	1.61	2.44	3.83	9.78	1.88	2.67
EV/EBITDA Ratio	-233.45	-233.45	-29.94	-5.46	-308.95	305.72
EV/EBIT Ratio	-26.21	-26.21	-4.18	-4.95	-2.29	-14.45
EV/FCF Ratio	-4.59	-4.59	-11.22	-4.07	-2.49	6.78
Debt / Equity Ratio	0.77	0.77	0.78	0.41	0.12	0.09
Debt / EBITDA Ratio	-61.95	-61.95	-5.73	-1.00	-45.02	25.10
Debt / FCF Ratio	-1.22	-1.22	-2.15	-0.75	-0.36	0.56
Quick Ratio	4.00	4.00	3.72	2.10	4.47	2.09
Current Ratio	3.73	3.73	3.38	1.73	3.81	1.95
Asset Turnover	0.31	0.31	0.24	0.09	0.20	0.20
Interest Coverage	-3.13	-3.13	-9.92	-12.21	-8.46	-3.17
Return on Equity (ROE)	-14.30%	-14.30%	-71.90%	-40.10%	-34.30%	-10.80%
Return on Assets (ROA)	-3.90%	-3.90%	-24.40%	-18.40%	-18.10%	-4.90%
Return on Capital (ROIC)	-13.80%	-13.80%	-59.57%	-31.53%	0.62%	0.67%
Earnings Yield	-5.04%	-3.73%	-20.74%	-16.65%	-24.28%	-4.85%
FCF Yield	-21.12%	-16.15%	-7.03%	-18.72%	-19.98%	7.86%
Buyback Yield / Dilution	-1.88%	-0.78%	-1.10%	-0.57%	-5.18%	-27.11%
Total Shareholder Return	-1.88%	-0.78%	-1.10%	-0.57%	-5.18%	-27.11%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).